Novelty seeking behaviour in Parkinson's disease

Neuropsychologia

Volumn 49, Issue 9, 2011, Pages 2483-2488

  Djamshidian, Atbin ^a   O'Sullivan, Sean S ^a   Wittmann, Bianca C ^b   Lees, Andrew J ^a   Averbeck, Bruno B ^c,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Dopamine; Impulsive compulsive behaviour; Learning; Novelty seeking; Parkinson's disease

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; BEHAVIOR; COMPULSION; CONTROLLED STUDY; DECISION MAKING; DRUG USE; FEMALE; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MENTAL TASK; NOVELTY SEEKING BEHAVIOR; PARKINSON DISEASE; SENSORY STIMULATION; TASK PERFORMANCE;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; AROUSAL; CASE-CONTROL STUDIES; CHOICE BEHAVIOR; COMPULSIVE BEHAVIOR; DOPAMINE AGONISTS; EXPLORATORY BEHAVIOR; FEMALE; GAMES, EXPERIMENTAL; HUMANS; IMPULSIVE BEHAVIOR; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MODELS, PSYCHOLOGICAL; PARKINSON DISEASE; PHOTIC STIMULATION; REFERENCE VALUES; REINFORCEMENT (PSYCHOLOGY);

EID: 79960186087     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2011.04.026     Document Type: Article

References (42)

1. Barratt E.S. Impulsiveness defined within a systems model of personality. Advances in personality assessment. 1985, 113-132. Lawrence Erlbaum Associates, Hillsdale, NJ. E.P. Speilburger, J.N. Butcher (Eds.).
2. Barratt E.S. Impulsiveness and aggression. Violence and mental disorder: Developments in risk assessment. 1994, 61-79. University of Chicago Press., Chicago. J. Monahan, H. Steadman (Eds.).
3. Belin D., Mar A.C., Dalley J.W., Robbins T.W., Everitt B.J. High impulsivity predicts the switch to compulsive cocaine-taking. Science 2008, 320(5881):1352-1355.
4. Bodi N., Keri S., Nagy H., Moustafa A., Myers C.E., Daw N., et al. Reward-learning and the novelty-seeking personality: A between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009, 132(Pt 9):2385-2395.
5. Braak H., Ghebremedhin E., Rub U., Bratzke H., Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell and Tissue Research 2004, 318(1):121-134.
6. Cilia R., Ko J.H., Cho S.S., van Eimeren T., Marotta G., Pellecchia G., et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling. Neurobiolgy of Disease 2010, 39(1):98-104.
7. Cools R., Clark L., Owen A.M., Robbins T.W. Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. Journal of Neuroscience 2002, 22(11):4563-4567.
8. Daffner K.R., Mesulam M.M., Scinto L.F., Cohen L.G., Kennedy B.P., West W.C., et al. Regulation of attention to novel stimuli by frontal lobes: An event-related potential study. Neuroreport 1998, 9(5):787-791.
9. Daw N.D., O'Doherty J.P., Dayan P., Seymour B., Dolan R.J. Cortical substrates for exploratory decisions in humans. Nature 2006, 441(7095):876-879.
10. Djamshidian A., Jha A., O'Sullivan S.S., Silveira-Moriyama L., Jacobson C., Brown P., et al. Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease. Movement Disorders 2010, 25(13):2203-2210.
11. Djamshidian A., O'Sullivan S.S., Lees A., Averbeck B.B. Stroop test performance in impulsive and non impulsive patients with Parkinson's disease. Parkinsonism and Related Disorders 2011, 17(3):212-214.
12. Dowling N., Smith D., Thomas T. Electronic gaming machines: Are they the′crack-cocaine′of gambling? Addiction 2005, 100(1):33-45.
13. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats.1: Behavioral data. Behavioural Brain Research 1988, 31(1):47-59.
14. Evans A.H., Katzenschlager R., Paviour D., O'Sullivan J.D., Appel S., Lawrence A.D., et al. Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome. Movement Disorders 2004, 19(4):397-405.
15. Evans A.H., Lawrence A.D., Potts J., Appel S., Lees A.J. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005, 65(10):1570-1574.
16. Evans A.H., Pavese N., Lawrence A.D., Tai Y.F., Appel S., Doder M., et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Annals of Neurology 2006, 59(5):852-858.
17. Evans S., Fleming S.M., Dolan R.J., Averbeck B.B. Effects of emotional preferences on value-based decision-making are mediated by mentalizing not reward networks. Journal of Cognitive Neuroscience 2010, [Epub ahead of print].
18. Ferrara J.M., Stacy M. Impulse-control disorders in Parkinson's disease. CNS Spectrums 2008, 13(8):690-698.
19. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12(3):189-198.
20. Frank M.J., Seeberger L.C., O'Reilly R.C. By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science 2004, 306(5703):1940-1943.
21. Frank M.J., Doll B.B., Oas-Terpstra J., Moreno F. Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation. Nature Neuroscience 2009, 12(8):1062-1068.
22. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease, Journal of Neurology. Neurosurgery and Psychiatry 1988, 51(6):745-752.
23. Goldstein R.Z., Craig A.D., Bechara A., Garavan H., Childress A.R., Paulus M.P., et al. The neurocircuitry of impaired insight in drug addiction. Trends in Cognitive Sciences 2009, 13(9):372-380.
24. Guitart-Masip M., Bunzeck N., Stephan K.E., Dolan R.J., Duzel E. Contextual novelty changes reward representations in the striatum. Journal of Neuroscience 2010, 30(5):1721-1726.
25. Housden C.R., O'Sullivan S.S., Joyce E.M., Lees A.J., Roiser J.P. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology 2010, 35(11):2155-2164.
26. Hughes R.N. Neotic preferences in laboratory rodents: issues, assessment and substrates. Neuroscience Biobehavioural Reviews 2007, 31(3):441-464.
27. Kelley A.E., Schochet T., Landry C.F. Risk taking and novelty seeking in adolescence: Introduction to part I. Annals of the New York Academy of Sciences 2004, 1021:27-32.
28. Lange L.A., Kampov-Polevoy A.B., Garbutt J.C. Sweet liking and high novelty seeking: Independent phenotypes associated with alcohol-related problems. Alcohol and Alcoholism 2010, 45(5):431-436.
29. Lawrence A.D., Evans A.H., Lees A.J. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?. Lancet Neurology 2003, 2(10):595-604.
30. Lenzenweger M.F. Schizotypy and schizophrenia: The view from experimental psychopathology 2010, Guilford Press.
31. Lim S.Y., Evans A.H., Miyasaki J.M. Impulse control and related disorders in Parkinson's disease: Review. Annals of the New York Academy of Sciences 2008, 1142:85-107.
32. Lisman J.E., Grace A.A. The hippocampal-VTA loop: Controlling the entry of information into long-term memory. Neuron 2005, 46(5):703-713.
33. O'Doherty J., Critchley H., Deichmann R., Dolan RJ Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices. Journal of Neuroscience 2003, 23(21):7931-7939.
34. O'Sullivan S.S., Wu K., Politis M., Lawrence A.D., Evans A.H., Bose S.K., et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011, 134(Pt 4):969-978.
35. Seo M., Beigi M., Jahanshahi M., Averbeck B.B. Effects of dopamine medication on sequence learning with stochastic feedback in Parkinson's disease. Front Syst Neurosci 2010, 4:36. 10.3389/fnsys.2010.00036.
36. Siri C., Cilia R., De Gaspari D., Canesi M., Meucci N., Zecchinelli A.L., et al. Cognitive status of patients with Parkinson's disease and pathological gambling. Journal of Neurology 2010, 257(2):247-252.
37. Steeves T.D., Miyasaki J., Zurowski M., Lang A.E., Pellecchia G., Van Eimeren T., et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A [11C] raclopride PET study. Brain 2009, 132(Pt 5):1376-1385.
38. Voon V., Potenza M.N., Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Current Opinion in Neurology 2007, 20(4):484-492.
39. Voon V., Thomsen T., Miyasaki J.M., de Souza M., Shafro A., Fox S.H., et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Archives of Neurology 2007, 64(2):212-216.
40. Voon V., Reynolds B., Brezing C., Gallea C., Skaljic M., Ekanayake V., et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) 2009, 207(4):645-659.
41. Voon V., Pessiglione M., Brezing C., Gallea C., Fernandez H.H., Dolan R.J., et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010, 65(1):135-142.
42. Wittmann B.C., Daw N.D., Seymour B., Dolan R.J. Striatal activity underlies novelty-based choice in humans. Neuron 2008, 58(6):967-973.